Next quarter’s earnings estimate for HCG is ₹0.74 with a range of ₹0.74 to ₹0.74. The previous quarter’s EPS was ₹1.47. HCG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
Next quarter’s earnings estimate for HCG is ₹0.74 with a range of ₹0.74 to ₹0.74. The previous quarter’s EPS was ₹1.47. HCG beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
HCG Sales Forecast
Next quarter’s sales forecast for HCG is ₹6.44B with a range of ₹6.44B to ₹6.44B. The previous quarter’s sales results were ₹6.45B. HCG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
Next quarter’s sales forecast for HCG is ₹6.44B with a range of ₹6.44B to ₹6.44B. The previous quarter’s sales results were ₹6.45B. HCG beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year HCG has Performed in-line its overall industry.
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.
HCG Analyst Recommendation Trends
Rating
Apr 25
Jul 25
Aug 25
Oct 25
Strong Buy
0
0
0
0
Buy
0
0
0
0
Hold
1
3
4
4
Sell
0
0
0
0
Strong Sell
0
0
0
0
total
1
3
4
4
In the current month, HCG has received 0Buy Ratings, 4Hold Ratings, and 0Sell Ratings. HCG average Analyst price target in the past 3 months is ―.
Each month's total comprises the sum of three months' worth of ratings.
HCG Stock Forecast FAQ
What is IN:HCG’s average 12-month price target, according to analysts?
Currently, no data Available
What is IN:HCG’s upside potential, based on the analysts’ average price target?
Currently there's no upside potential for IN:HCG, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is HealthCare Global Enterprises Ltd. a Buy, Sell or Hold?
HealthCare Global Enterprises Ltd. has a consensus rating of Hold, which is based on 0 buy ratings, 0 hold ratings and 0 sell ratings.
What is HealthCare Global Enterprises Ltd.’s share price target?
Currently, no data Available
What do analysts say about HealthCare Global Enterprises Ltd.?
HealthCare Global Enterprises Ltd.’s analyst rating consensus is a Hold. This is based on the ratings of 0 Wall Streets Analysts.
How can I buy shares of HealthCare Global Enterprises Ltd.?
To buy shares of IN:HCG, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.